Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1126 of 5804
-
Can headphones silence the stress of a noisy heart procedure?
Symptom relief CompletedBackground: Rotational atherectomy (RA) generates high-intensity drilling noise concentrated around 3000 Hz, creating a distinctive auditory stressor that may exacerbate perioperative anxiety and autonomic dysregulation in patients undergoing percutaneous coronary intervention. D…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New hope for dialysis patients: drug targets dangerous phosphorus levels
Disease control Recruiting nowA phase 3, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis
Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New shot shows promise for severe eczema sufferers
Symptom relief OngoingThis trial was designed to evaluate the efficacy and safety of SHR-1819 in adult patients with moderate-to-severe atopic dermatitis.
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo aims to shrink prostate tumors before surgery
Disease control Recruiting nowThe purpose of this study is to find out whether BMS986365 in combination with degarelix, given before standard surgical treatment (radical prostatectomy), is a safe and effective treatment that causes few or mild side effects for people who have localized high-risk prostate canc…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Veterans find migraine relief without pills using wearable device
Symptom relief CompletedAmong US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine amon…
Phase: PHASE4 • Sponsor: Theranica • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Could a seizure drug lift bipolar depression?
Symptom relief Recruiting nowInitially, observational studies suggested a possible effect of Lacosamide on depressive and anxious symptoms in individuals with epilepsy, and later, an open-label study demonstrated the efficacy of lacosamide in improving depressive and manic symptoms in individuals with bipola…
Phase: PHASE3 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a diabetes drug help hearts heal better after a heart attack?
Disease control Recruiting nowAcute myocardial infarction (MI) remains one of the leading causes of cardiovascular morbidity and mortality worldwide. It most commonly occurs due to acute coronary artery occlusion following rupture or erosion of an atherosclerotic plaque and subsequent thrombus formation. Desp…
Sponsor: University of Athens • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New program aims to tame Africa's blood pressure crisis
Disease control Recruiting nowThe ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous a…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New pill takes aim at genetic weakness in tough blood cancers
Disease control Recruiting nowThe purpose of this study is to understand the safety, tolerability, efficacy, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy of orally administered AZD3632 in participants with advanced haematologic malignancies with KMT2Ar, NPM1m, or other genotypes associ…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug buntanetap tested for Long-Term safety in Parkinson's patients
Disease control Recruiting nowThis study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conducted with two cohorts. Cohort 1 will enroll via invitation only for PD participants who have previously participated in bun…
Phase: PHASE2, PHASE3 • Sponsor: Annovis Bio Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Gene therapy injection aimed at slowing ALS enters human testing
Disease control Recruiting nowThe primary objective of this dose-finding study is to evaluate the safety, tolerability and pharmacodynamics of single dose of INS1202 via IT administration in participants ≥ 18 to \<80 years of age with ALS who carry superoxide dismutase type 1 (SOD1) mutations or harbor no kno…
Phase: PHASE1 • Sponsor: Insmed Gene Therapy LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New asthma pill shows promise in early trial
Symptom relief Recruiting nowThis study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LA…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to protect kidneys in diabetes
Disease control Recruiting nowThis study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidney disease. The aim of the study is to see how safe and effective the study drugs are. The study is looking at several …
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope: Stomach-Stitching procedure aims to cut obesity risks in endometrial cancer survivors
Disease control Recruiting nowObesity increases the risk of endometrial cancer, with higher Body Mass Index (BMI) leading to a significant increase in both cancer risk and recurrence. Because of the excellent cancer-specific outcomes and preponderance of obesity-related complications, women with endometrial c…
Sponsor: Centro di Riferimento Oncologico - Aviano • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for cancer patients who stopped responding to immunotherapy?
Disease control Recruiting nowThe goal of this clinical trial is to learn what dose of ruxolitinib can be given safely together with retifanlimab in patients with metastatic renal cell carcinoma and non-small cell lung carcinoma. The main question it aims to answer is: What is the maximum dose of ruxolitini…
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for Hard-to-Treat cancers: experimental drug targets KRAS mutation
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of RMC-5127 as a monotherapy and in combination with either daraxonrasib or cetuximab in adults with KRAS G12V-mutant solid tumors.
Phase: PHASE1 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for kids with fabry: migalastat trial opens
Disease control Recruiting nowAn open-label study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of migalastat treatment in pediatric subjects 2 to \< 12 years of age with Fabry disease and with amenable GLA variants.
Phase: PHASE3 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New device could help colon cancer patients avoid a stoma bag
Disease control ENROLLING_BY_INVITATIONColorectal cancer is the third most common malignancy worldwide and the second most common in the US. It is the second leading cause of cancer death worldwide, with 1.8 million new cases and 862,000 deaths per year. The majority of patients receive surgical treatment. Colorectal …
Phase: NA • Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Brain-Health app and coaching trial aims to prevent dementia in At-Risk seniors
Prevention Not yet recruitingThe goal of this clinical trial is to learn whether a hybrid multidomain lifestyle program can prevent cognitive decline and reduce dementia risk in community-dwelling adults in mid- to late life who are at increased risk of Alzheimer´s disease or related dementias but do not yet…
Phase: NA • Sponsor: Medical University of Vienna • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Could a common diabetes drug heal scarred hearts?
Disease control Not yet recruitinghis is a single-center, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effect of Henagliflozin (an SGLT2 inhibitor) on myocardial fibrosis burden in patients with non-obstructive hypertrophic cardiomyopathy (nHCM). The study will use 68 68 Ga…
Phase: NA • Sponsor: Shanghai East Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC